Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-55.25%
operating margin TTM
-51.66%
revenue TTM
285.27 Million
revenue per share TTM
4.71$
valuation ratios | |
|---|---|
| pe ratio | -38.20 |
| peg ratio | -2.05 |
| price to book ratio | -55.22 |
| price to sales ratio | 21.14 |
| enterprise value multiple | -66.76 |
| price fair value | -55.22 |
profitability ratios | |
|---|---|
| gross profit margin | 84.88% |
| operating profit margin | -51.66% |
| pretax profit margin | -53.82% |
| net profit margin | -55.25% |
| return on assets | -24.92% |
| return on equity | 186.87% |
| return on capital employed | -165.81% |
liquidity ratios | |
|---|---|
| current ratio | 1.02 |
| quick ratio | 0.69 |
| cash ratio | 0.53 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 1,492.61 |
| operating cycle | 1,574.76 |
| days of payables outstanding | 461.09 |
| cash conversion cycle | 1,113.68 |
| receivables turnover | 4.44 |
| payables turnover | 0.79 |
| inventory turnover | 0.24 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.73 |
| debt equity ratio | -4.23 |
| long term debt to capitalization | 3.80 |
| total debt to capitalization | 1.31 |
| interest coverage | -5.45 |
| cash flow to debt ratio | -0.21 |
cash flow ratios | |
|---|---|
| free cash flow per share | -2.83 |
| cash per share | 8.17 |
| operating cash flow per share | -2.73 |
| free cash flow operating cash flow ratio | 1.04 |
| cash flow coverage ratios | -0.21 |
| short term coverage ratios | -0.37 |
| capital expenditure coverage ratio | -27.83 |
Frequently Asked Questions
When was the last time Ascendis Pharma A/S (NASDAQ:ASND) reported earnings?
Ascendis Pharma A/S (ASND) published its most recent earnings results on 07-08-2025.
What is Ascendis Pharma A/S's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Ascendis Pharma A/S (NASDAQ:ASND)'s trailing twelve months ROE is 186.87%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Ascendis Pharma A/S (ASND) currently has a ROA of -24.92%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ASND's net profit margin stand at?
ASND reported a profit margin of -55.25% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ASND's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.02 in the most recent quarter. The quick ratio stood at 0.69, with a Debt/Eq ratio of -4.23.